Jakarta - Delayed Quote IDR

PT Itama Ranoraya Tbk (IRRA.JK)

474.00 -16.00 (-3.27%)
At close: April 26 at 4:14 PM GMT+7
Key Events
Loading Chart for IRRA.JK
DELL
  • Previous Close 490.00
  • Open 474.00
  • Bid 482.00 x --
  • Ask 472.00 x --
  • Day's Range 472.00 - 490.00
  • 52 Week Range 436.00 - 1,045.00
  • Volume 1,881,400
  • Avg. Volume 6,368,837
  • Market Cap (intraday) 714.707B
  • Beta (5Y Monthly) 0.94
  • PE Ratio (TTM) 140.65
  • EPS (TTM) 3.37
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Aug 9, 2022
  • 1y Target Est --

PT Itama Ranoraya Tbk trades in laboratory and pharmaceutical equipment, and medical devices in Indonesia. It offers electromedical and non-electromedical medical equipment, in vitro diagnostic products, and other products. The company's products include Covid and infectious disease rapid test, abbott, auto disable syringe, disinfectant, and other products, as well as USG machine. It is also involved in the office space rental business. The company was founded in 1988 and is headquartered in Jakarta Timur, Indonesia. PT Itama Ranoraya Tbk is a subsidiary of PT Global Dinamika Kencana.

www.itama.co.id

221

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: IRRA.JK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IRRA.JK
40.75%
IDX COMPOSITE
3.25%

1-Year Return

IRRA.JK
42.89%
IDX COMPOSITE
3.14%

3-Year Return

IRRA.JK
72.93%
IDX COMPOSITE
16.94%

5-Year Return

IRRA.JK
--
IDX COMPOSITE
14.26%

Compare To: IRRA.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IRRA.JK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    714.71B

  • Enterprise Value

    863.54B

  • Trailing P/E

    140.65

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.05

  • Price/Book (mrq)

    1.56

  • Enterprise Value/Revenue

    1.24

  • Enterprise Value/EBITDA

    27.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.75%

  • Return on Assets (ttm)

    1.87%

  • Return on Equity (ttm)

    1.10%

  • Revenue (ttm)

    696.3B

  • Net Income Avi to Common (ttm)

    5.2B

  • Diluted EPS (ttm)

    3.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    92.03B

  • Total Debt/Equity (mrq)

    52.45%

  • Levered Free Cash Flow (ttm)

    -69.94B

Company Insights: IRRA.JK

People Also Watch